Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EHA 2017 | Myeloma UK: exciting clinical trials investigating treatments for MM

Rakesh Popat • 22 Jun 2017
EHA 2017
Multiple Myeloma Cyclophosphamide Daratumumab Dexamethasone Ixazomib Lenalidomide

Rakesh Popat, MD, PhD, from University College London, London, UK, provides us an insight into the Clinical Trial Network run by Myeloma UK with the aim of effectively treating diseases including multiple myeloma (MM). Trials mentioned by Dr. Popat include the MUK9b trial (NCT03188172), evaluating the combination of daratumumab, revlimid and dexamethasone in treating MM, and the MUK8 trial (NCT02461888), which is investigating ixazomib in combination with cyclophosphamide and dexamethasone for the treatment of MM. This interview was filmed at the European Hematology Association (EHA) 2017 Annual Congress in Madrid, Spain.

More from Rakesh Popat

2:06
The optimal sequencing of CAR-T and other immunotherapies in multiple myeloma
Rakesh Popat • 16 Feb 2024
3:46
'Clinical case discussions' session rundown: HLH/MAS, aseptic meningitis, & CAR-NK cells in MM
Rakesh Popat • 16 Feb 2024
1:30
Selecting patients with myeloma for CAR-T: important clinical considerations
Rakesh Popat • 16 Feb 2024
1:14
The potential of CELMoDs for the treatment of R/R multiple myeloma
Rakesh Popat • 10 Dec 2023

Related Videos

0:59
Looking forward to COMy 2024: celebrating 10 years
Mohamad Mohty • 17 Apr 2024
0:57
Overcoming barriers to treating older patients with myeloma
Sergio Giralt • 16 Apr 2024
1:01
The potentially curative role of CAR-T therapy in myeloma
Sergio Giralt • 16 Apr 2024
1:45
Expanded approval of cilta-cel in myeloma: the value of bringing CAR-T cells into earlier lines
Monika Engelhardt • 16 Apr 2024
The content of VJHemOnc is intended for healthcare professionals